These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38639831)

  • 21. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
    Rossing K; Christensen PK; Jensen BR; Parving HH
    Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
    Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension-A randomized, open-label, active-controlled, superiority, parallel-group clinical trial.
    Hwang YC; Yoon KH; Cha BS; Lee KW; Jang HC; Min KW; Chung CH; Lee MK
    Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28840637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time course for blood pressure lowering of dihydropyridine calcium channel blockers.
    Ghamami N; Chiang SH; Dormuth C; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010052. PubMed ID: 25173808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.
    Abe M; Maruyama N; Okada K; Matsumoto S; Matsumoto K; Soma M
    Hypertens Res; 2011 Aug; 34(8):935-41. PubMed ID: 21654755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney Function After a Hypertensive Disorder of Pregnancy: A Longitudinal Study.
    Paauw ND; van der Graaf AM; Bozoglan R; van der Ham DP; Navis G; Gansevoort RT; Groen H; Lely AT
    Am J Kidney Dis; 2018 May; 71(5):619-626. PubMed ID: 29289477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of Calcium Channel Blockers on Moderate or Severe Albuminuria in Diabetic, Hypertensive Patients.
    Cativo EH; Lopez PD; Cativo DP; Atlas SA; Rosendorff C
    Am J Med; 2021 Jan; 134(1):104-113.e3. PubMed ID: 32645341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.
    Kato J; Yokota N; Tamaki N; Kariya S; Kita T; Ayabe T; Eto T; Kitamura K
    Hypertens Res; 2011 Mar; 34(3):331-5. PubMed ID: 21124326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.
    Ferreira JP; Zannad F; Butler J; Filippatos G; Pocock SJ; Brueckmann M; Steubl D; Schueler E; Anker SD; Packer M
    JAMA Cardiol; 2022 Nov; 7(11):1148-1159. PubMed ID: 36129693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD.
    Blum MF; Surapaneni A; Stewart JD; Liao D; Yanosky JD; Whitsel EA; Power MC; Grams ME
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):311-319. PubMed ID: 32108020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and microalbuminuria.
    Katayama K; Nomura S; Ishikawa H; Murata T; Koyabu S; Nakano T
    Kidney Int; 2006 Jul; 70(1):151-6. PubMed ID: 16710356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
    Bakris GL; Toto RD; McCullough PA; Rocha R; Purkayastha D; Davis P;
    Kidney Int; 2008 Jun; 73(11):1303-9. PubMed ID: 18354383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of the Association of Hypobicarbonatemia and Incident Kidney Failure With Replacement Therapy by Venous pH: A Cohort Study.
    Kajimoto S; Sakaguchi Y; Asahina Y; Kaimori JY; Isaka Y
    Am J Kidney Dis; 2021 Jan; 77(1):35-43. PubMed ID: 32828983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PAIT-Survey Follow-Up: Changes in Albuminuria in Hypertensive Diabetic Patients with Mild-Moderate Chronic Kidney Disease.
    Fici F; Ari Bakir E; Ilkay Yüce E; Kanuncu S; Makel W; Tarim BA; Robles NR
    High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):43-49. PubMed ID: 31916208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum Level of Polyubiquitinated PTEN and Loss of Kidney Function in American Indians With Type 2 Diabetes.
    Looker HC; Lin C; Nair V; Kretzler M; Mauer M; Najafian B; Nelson RG
    Am J Kidney Dis; 2022 Apr; 79(4):497-506. PubMed ID: 34562525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary albumin excretion during angiotensin II receptor blockade: comparison of combination treatment with a diuretic or a calcium-channel blocker.
    Matsui Y; Eguchi K; Ishikawa J; Shimada K; Kario K
    Am J Hypertens; 2011 Apr; 24(4):466-73. PubMed ID: 21164498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and rationale of the study of assessment for kidney function by urinary microalbumin in randomized (SAKURA) trial.
    Matsuoka H; Ando K; Ueshima K; Babazono T; Kario K; Tanaka S; Nakao K; Fujita T;
    Clin Exp Hypertens; 2011; 33(7):455-62. PubMed ID: 21649534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.